- Report
- June 2025
- 134 Pages
Global
From €5258EUR$5,850USD£4,459GBP
- Report
- April 2025
- 200 Pages
Global
From €4035EUR$4,490USD£3,422GBP
- Report
- February 2025
- 141 Pages
Global
From €3550EUR$3,950USD£3,011GBP
- Report
- July 2024
- 306 Pages
Global
From €4489EUR$4,995USD£3,807GBP
- Report
- October 2023
- 243 Pages
Global
From €4821EUR$5,552USD£3,950GBP
- Report
- June 2023
- 58 Pages
Global
From €1797EUR$2,000USD£1,524GBP
- Report
- July 2023
- 114 Pages
Global
From €4179EUR$4,650USD£3,544GBP
- Report
- June 2023
- 78 Pages
Global
From €4449EUR$4,950USD£3,773GBP
- Report
- September 2023
- 110 Pages
Global
From €5347EUR$5,950USD£4,535GBP
- Report
- December 2024
- 136 Pages
Spain
From €2247EUR$2,500USD£1,905GBP
- Report
- June 2024
- 175 Pages
Global
From €2247EUR$2,500USD£1,905GBP
- Report
- November 2023
- 70 Pages
United States
From €2674EUR$2,975USD£2,267GBP
€3146EUR$3,500USD£2,668GBP
- Report
- July 2023
- 73 Pages
China
From €2674EUR$2,975USD£2,267GBP
€3146EUR$3,500USD£2,668GBP
- Report
- December 2022
- 87 Pages
Asia Pacific
From €3056EUR$3,400USD£2,591GBP
€3595EUR$4,000USD£3,049GBP
- Report
- October 2021
- 118 Pages
Global
From €3438EUR$3,825USD£2,915GBP
€4044EUR$4,500USD£3,430GBP
- Report
- February 2024
- 120 Pages
Global
From €4269EUR$4,750USD£3,620GBP
- Report
- February 2024
- 119 Pages
Global
From €4269EUR$4,750USD£3,620GBP
From €4269EUR$4,750USD£3,620GBP
- Report
- April 2023
- 75 Pages
China
From €4269EUR$4,750USD£3,620GBP
- Report
- April 2023
- 80 Pages
Germany
From €4269EUR$4,750USD£3,620GBP

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more